Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding

Rationale: Cystic fibrosis (CF) lung disease progresses by a combination of airway inflammation, bacterial colonization, and infection. Airway inflammation is predominantly neutrophilic and complicates airway clearance therapies through cellular debris; excessive DNA; excessive and viscous mucus; an...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Am Thorac Soc
Prif Awduron: Zeitlin, Pamela L., Diener-West, Marie, Callahan, Karen A., Lee, Seakwoo, Talbot, C. Conover, Pollard, Bette, Boyle, Michael P., Lechtzin, Noah
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Thoracic Society 2017
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5427734/
https://ncbi.nlm.nih.gov/pubmed/28006108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201608-649OC
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg